ABSTRACT
INTRODUCTION AND OBJECTIVE: Fascia Manipulation® is one of the methods focusing on the deep fascia. The assumption is that fascial manipulation is carried out on precisely determined points - coordination centres (cc), and on a limited area so as the friction occurring during manipulation would cause a local rise in temperature due to the inflammatory reaction. Rise in temperature influences modification in consistency of elementary matter in the manipulated area, and by the same token causing a decrease in the negative effects of fascia densification which stems from accumulation of hyaluronic acid. The purpose of the research is to prove the thesis that fascial manipulation causes local rise in temperature due to inflammatory reaction. MATERIAL AND METHODS: For the research, 25 individuals with densification in lower limb area were qualified. They were exposed to a single, 3-minute facial manipulation®. By means of a thermal-imaging camera, changes in the temperature of the body in the examined area were evaluated. The body's temperature evaluation was carried out 8 times: before the treatment, 5 minutes after the treatment, and, next, 6, 12, 18, 24, 36, 48 hours after the treatment. RESULTS: The average surface temperature of the treated area before mobilization was 33.4°C. A statistically relevant increase in temperature was already observed 5 minutes after the treatment (increase of 0.5°C; p<0.001). However, the highest temperature was observed 24 hours after mobilization (increase of 2.4°C). The difference between the first and 7 other measurements was statistically relevant (p<0.001). CONCLUSIONS: The statistically relevant increase in temperature under the influence of fascial manipulation® in the treatment area can confirm the occurrence of inflammatory reaction.
Subject(s)
Connective Tissue Diseases/therapy , Fascia/physiopathology , Musculoskeletal Manipulations , Adult , Body Temperature , Connective Tissue Diseases/immunology , Connective Tissue Diseases/physiopathology , Fascia/immunology , Female , Humans , Male , Thermography , Young AdultABSTRACT
Reactive perforating dermatosis is a rare chronic skin disease defined by the transepidermal elimination of collagen and/or elastin. In the acquired form in adults, it is frequently associated with diseases such as diabetes and chronic renal failure. No systematic reviews of treatment options are available for this disease. The aim of this systematic review is to summarize all reported treatment options for acquired reactive perforating dermatosis (ARPD). This is a systematic review based on a MEDLINE search of articles in English and German from 1990 to 2016. Most medical literature on the treatment of ARPD is limited to individual case reports and small series of patients. Various therapies that have been tried include antihistamines, topical keratolytics, corticosteroids, tretinoin, oral drugs such as allopurinol or antibiotics, and phototherapy or photochemotherapy. While there are no specific criteria for the evidence-based selection of treatment options for ARPD, the first priority in management of these conditions should be treatment of an underlying disease if present. None of the described modalities has been approved for first-line therapy. It is recommended to choose a combination of drugs that reduce itching and assist in the resolution of the skin lesions at the same time.
Subject(s)
Connective Tissue Diseases , Skin Diseases , Connective Tissue Diseases/diagnosis , Connective Tissue Diseases/etiology , Connective Tissue Diseases/therapy , Diabetes Complications , Humans , Kidney Failure, Chronic/complications , Photochemotherapy , Pruritus , Skin Diseases/diagnosis , Skin Diseases/etiology , Skin Diseases/therapy , Ultraviolet TherapyABSTRACT
The most recent information on fascial tissue indicates that there are not fascial layers, but polyhedral microvacuoles of connective tissue, which connect the body systems and, by hosting specialized cells, permit several functions, such as motor, nervous, vascular and visceral. These microvacuoles (a repetition of polyhedral units of connective fibrils) under internal or external tension change shape and can manage the movement variations, regulating different body functions and ensuring the maintenance of efficiency of the body systems. Their plasticity is based on perfect functional chaos: it is not possible to determine the motion vectors of the different fibrils, which differ in behavior and orientation; this strategy confers to the fascial continuum the maximum level of adaptability in response to the changing internal and external conditions of the cell. The present commentary deals with this concept, providing clinical examples of different disease patterns, providing contrary examples in which this adaptability does not occur, and lastly suggesting considerations for the approach to manipulative therapy of the fascial tissue. The fascial continuum is like a flock of birds flying together without a predetermined logic and maintaining their individuality at the same time.
Subject(s)
Fascia/physiology , Adaptation, Physiological , Cell Plasticity , Connective Tissue Diseases/therapy , Fascia/blood supply , HumansABSTRACT
Biologic therapy continues to revolutionize the treatment of autoimmune disease, especially in rheumatology as the pathophysiology of both inflammation and autoimmune disease becomes better understood. These therapies are designed to dampen the response of the inflammatory cascades. Although the first biologic therapies were approved many years ago, expanding indications and new agents continue to challenge the traditional treatment strategies for rheumatic diseases. This article reviews the data supporting the current use of biologic therapies, including off-label indications, in a subset of rheumatic diseases including rheumatoid arthritis, lupus, inflammatory myositis, ankylosing spondylitis, psoriatic arthritis, vasculitis, and gout.
Subject(s)
Autoimmune Diseases/therapy , Biological Therapy , Connective Tissue Diseases/therapy , Antibodies, Monoclonal/therapeutic use , Antirheumatic Agents/therapeutic use , Arthritis, Psoriatic/immunology , Arthritis, Psoriatic/therapy , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/therapy , Autoimmune Diseases/immunology , Biological Products/therapeutic use , Biological Therapy/methods , Connective Tissue Diseases/immunology , Gout/therapy , Humans , Immunologic Factors/therapeutic use , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/therapy , Spondylitis, Ankylosing/immunology , Spondylitis, Ankylosing/therapy , Treatment Outcome , Vasculitis/immunology , Vasculitis/therapyABSTRACT
In the past 15 years, multiple articles have appeared that target fascia as an important component of treatment in the field of physical medicine and rehabilitation. To better understand the possible actions of fascial treatments, there is a need to clarify the definition of fascia and how it interacts with various other structures: muscles, nerves, vessels, organs. Fascia is a tissue that occurs throughout the body. However, different kinds of fascia exist. In this narrative review, we demonstrate that symptoms related to dysfunction of the lymphatic system, superficial vein system, and thermoregulation are closely related to dysfunction involving superficial fascia. Dysfunction involving alterations in mechanical coordination, proprioception, balance, myofascial pain, and cramps are more related to deep fascia and the epimysium. Superficial fascia is obviously more superficial than the other types and contains more elastic tissue. Consequently, effective treatment can probably be achieved with light massage or with treatment modalities that use large surfaces that spread the friction in the first layers of the subcutis. The deep fasciae and the epymisium require treatment that generates enough pressure to reach the surface of muscles. For this reason, the use of small surface tools and manual deep friction with the knuckles or elbows are indicated. Due to different anatomical locations and to the qualities of the fascial tissue, it is important to recognize that different modalities of approach have to be taken into consideration when considering treatment options.
Subject(s)
Connective Tissue Diseases/therapy , Fascia , Muscular Diseases/therapy , Connective Tissue Diseases/diagnosis , Connective Tissue Diseases/etiology , Humans , Muscular Diseases/diagnosis , Muscular Diseases/etiologyABSTRACT
In common rheumatologic diseases skin findings are an important diagnostic clue for astute clinicians. Skin manifestations can help identify systemic disease or may require therapy uniquely targeted at the cutaneous problem. This article discusses 3 common rheumatologic conditions seen in adults by dermatologists: cutaneous lupus, dermatomyositis, and morphea. The focus is on the cutaneous findings and clinical presentation. Some approaches to treatment are explored. Clues to help identify systemic disease are also highlighted.
Subject(s)
Connective Tissue Diseases/diagnosis , Connective Tissue Diseases/therapy , Antibodies/blood , Antirheumatic Agents/therapeutic use , Calcineurin Inhibitors/therapeutic use , Diagnosis, Differential , Glucocorticoids/therapeutic use , Humans , Medical History Taking , Paraneoplastic Syndromes/diagnosis , Phototherapy , Physical ExaminationABSTRACT
Connective-tissue disorders, which include lupus erythematosus, morphoea/scleroderma and dermatomyositis, are characterized by cutaneous manifestations that are sometimes resistant to conventional therapy. Light treatments, which include phototherapy, photodynamic therapy (PDT) and photopheresis, are routinely utilized in the treatment of dermatological conditions and may provide unique mechanisms of action in the treatment of these connective-tissue disorders. The objective of this study is to conduct a review of the literature that describes the use of phototherapy, PDT and photopheresis in the treatment of lupus erythematosus, morphoea/scleroderma and dermatomyositis. A MEDLINE search was conducted to find articles that discuss treatment of connective-tissue diseases with light therapies and more than 30 publications that discuss light therapy for these diseases were identified. These range in design from case reports to randomized, prospective trials. Study outcomes and details were summarized and presented within each connective-tissue disease by light therapy modality, which includes phototherapy, PDT and photopheresis. Although there is a known association between photosensitivity and connective-tissue diseases, light therapies, when used appropriately, may be legitimate therapeutic options for recalcitrant cutaneous manifestations in lupus erythematosus, morphoea/scleroderma and dermatomyositis.
Subject(s)
Connective Tissue Diseases/therapy , Photochemotherapy/methods , Photopheresis/methods , Phototherapy/methods , Epidemiologic Methods , HumansABSTRACT
Patients with connective tissue disease often suffer from pulmonary complications, including interstitial lung disease and pulmonary hypertension. Supportive care for these patients aims to relieve symptoms and improve activity level and quality of life. A holistic approach to the management of patients with advanced connective tissue disease-associated pulmonary disorders includes a full assessment of patient symptoms as well as a careful search for side effects of treatment and treatable comorbidities. This article addresses supportive measures such as supplemental oxygen and pulmonary rehabilitation. Issues related to quality of life, sleep disturbances, and identification of mood disorders are discussed. In addition, we review significant comorbidities, including cardiovascular disease, glucocorticoid-induced osteoporosis, and gastroesophageal reflux disease. Essential facets of advanced lung disease, including mechanical ventilation, lung transplantation, end-of-life care, and hospice, are covered.
Subject(s)
Connective Tissue Diseases/complications , Hypertension, Pulmonary/complications , Lung Diseases, Interstitial/etiology , Connective Tissue Diseases/physiopathology , Connective Tissue Diseases/therapy , Holistic Health , Hospice Care/methods , Humans , Hypertension, Pulmonary/physiopathology , Hypertension, Pulmonary/therapy , Lung Diseases, Interstitial/physiopathology , Lung Diseases, Interstitial/therapy , Quality of Life , Respiration, Artificial/methods , Terminal Care/methodsABSTRACT
Autoimmune skin disease occurs in pregnancy, and treatment is often required to control both maternal disease and fetal outcomes. Here we present the available safety data in pregnancy and lactation for medications used to treat autoimmune skin diseases, including cutaneous lupus erythematosus, dermatomyositis, morphea and systemic sclerosis, pemphigus vulgaris, pemphigus foliaceus, and pemphigoid gestationis. A PubMed search of the English-language literature using keywords, "pregnancy" "rheumatic disease," and "connective tissue disease" was performed. Relevant articles found in the search and references were included. Reasonable evidence supports the careful and cautious use of topical steroids, topical calcineurin inhibitors, systemic corticosteroids, hydroxychloroquine, and azathioprine in pregnancy. Case reports or clinical experience suggest intravenous immunoglobulin, dapsone, phototherapy, rituximab, and plasmapheresis may be safe. Several treatment options exist for autoimmune skin disease in pregnancy and lactation, and should be considered when treating these patients.
Subject(s)
Autoimmune Diseases/therapy , Blister/therapy , Connective Tissue Diseases/therapy , Pregnancy Complications/therapy , Skin Diseases/therapy , Adrenal Cortex Hormones/therapeutic use , Azathioprine/therapeutic use , Calcineurin Inhibitors , Female , Humans , Hydroxychloroquine/therapeutic use , Phototherapy , PregnancyABSTRACT
The article covers results of studies concerning time of fluorosis development in patients with signs of connective tissue dysplasia syndrome (CTDS). if compared with patients without CTDS, and of studies concerning hyperostosis coefficient in accordance with presence or absence of CTDS. Efficiency of physical therapy and balneotherapy for these patients are also reported by the authors.
Subject(s)
Connective Tissue Diseases , Fluorides, Topical/poisoning , Hyperostosis , Occupational Diseases , Occupational Exposure/adverse effects , Adult , Balneology/methods , Cohort Studies , Connective Tissue Diseases/epidemiology , Connective Tissue Diseases/etiology , Connective Tissue Diseases/physiopathology , Connective Tissue Diseases/therapy , Disease Progression , Exercise Therapy/methods , Humans , Hyperostosis/epidemiology , Hyperostosis/etiology , Hyperostosis/physiopathology , Hyperostosis/therapy , Male , Metallurgy , Occupational Diseases/epidemiology , Occupational Diseases/etiology , Occupational Diseases/therapy , Russia/epidemiology , Severity of Illness Index , Syndrome , Time Factors , Treatment Outcome , Workforce , Young AdultSubject(s)
Biological Products/therapeutic use , Phytotherapy/statistics & numerical data , Practice Patterns, Physicians' , Algorithms , Ankle Injuries/drug therapy , Connective Tissue Diseases/therapy , Drug Delivery Systems/methods , Drug Delivery Systems/statistics & numerical data , Humans , Molecular Targeted Therapy/methods , Molecular Targeted Therapy/statistics & numerical data , Musculoskeletal Diseases/therapy , Pharmaceutical Preparations/administration & dosage , Sprains and Strains/drug therapyABSTRACT
Cellulite is a disorder in which adipose tissue extends through the dermis, producing a cosmetically displeasing dimpling in the affected areas. While many treatments claim to be able to improve the appearance of cellulite, the long-term effectiveness of these treatments and whether the logic behind these treatments can lead to a long-term improvement has not been extensively reviewed. In the following review, our goal is to assess the various cellulite treatments and evaluate the length of time results persist and whether the science behind the treatments warrants them as reliable and effective treatments for cellulite.
Subject(s)
Connective Tissue Diseases/therapy , Cosmetic Techniques , Subcutaneous Fat , Humans , Lipectomy , Massage , Mesotherapy , Phototherapy , Radiofrequency Therapy , Suction , Time Factors , Ultrasonic TherapyABSTRACT
Lymphedema and lipedema are chronic progressive disorders for which no causal therapy exists so far. Many general practitioners will rarely see these disorders with the consequence that diagnosis is often delayed. The pathophysiological basis is edematization of the tissues. Lymphedema involves an impairment of lymph drainage with resultant fluid build-up. Lipedema arises from an orthostatic predisposition to edema in pathologically increased subcutaneous tissue. Treatment includes complex physical decongestion by manual lymph drainage and absolutely uncompromising compression therapy whether it is by bandage in the intensive phase to reduce edema or with a flat knit compression stocking to maintain volume.
Subject(s)
Compression Bandages , Connective Tissue Diseases/therapy , Drainage , Edema/therapy , Lymphedema/therapy , Stockings, Compression , Subcutaneous Fat/physiopathology , Connective Tissue Diseases/diagnosis , Connective Tissue Diseases/physiopathology , Connective Tissue Diseases/surgery , Edema/diagnosis , Edema/physiopathology , Edema/surgery , Humans , Lipectomy , Lymphedema/diagnosis , Lymphedema/physiopathology , Lymphedema/surgery , Patient Selection , Treatment OutcomeABSTRACT
The descriptive cross sectional surveys were carried out among the outstanding clinical physicians in the field of acupuncture and moxibustion by using the survey sampling. The fuzzy comprehensive evaluation techniques was applied to evaluate the opinions of clinical experts in the field of acupuncture and moxibustion in order to classify the spectrum of diseases related to the musculoskeletal and connective tissue. After the statistical analysis on sixty-four diseases with 104 subtypes, the spectrum of diseases were determined as grade I spectrum of diseases with 13 subtypes of diseases, grade II spectrum of diseases with 51 subtypes of diseases, grade III spectrum of diseases with 10 subtypes of diseases, and grade IV spectrum of diseases with 30 subtypes of diseases. The outcomes reveal that acupuncture and moxibustion therapy have been applied widely for musculoskeletal diseases and connective tissue related diseases.
Subject(s)
Acupuncture Therapy/methods , Bone Diseases/therapy , Connective Tissue Diseases/therapy , Moxibustion/methods , Muscular Diseases/therapy , Cross-Sectional Studies , Humans , Surveys and QuestionnairesABSTRACT
In the late 1980s, the murine monoclonal antibody muromonab was used in children undergoing organ transplantation. Since then, dozens of new molecules have been developed to modulate the immune response, block growth factors, or prevent infections on the basis of the antigen-antibody-specific response. In pediatrics, most biological therapies are used off-label, although they are effective and well tolerated and are used as first-line therapy in some severe genetic diseases. Biologicals allow specific targeting and can be engineered against any antigen. The safety of these treatments varies depending on the molecule and precise knowledge of side effects is essential for clinicians. The development of these promising agents requires clinical trials in children to validate their effectiveness and safety in the medium and long term.
Subject(s)
Antibodies, Monoclonal/therapeutic use , Antineoplastic Agents/therapeutic use , Biological Therapy , Immunosuppressive Agents/therapeutic use , Pediatrics/trends , Child , Communicable Diseases/therapy , Connective Tissue Diseases/therapy , Graft Rejection/prevention & control , Humans , Immune System Diseases/therapy , Neoplasms/therapyABSTRACT
BACKGROUND: Calciphylaxis and calcinosis can both cause severe morbidity and mortality in patients with systemic lupus erythematosus (SLE). Haematopoietic stem cell transplantation (HSCT) has been successfully used to treat patients with refractory SLE. It was hypothesized that in calciphylaxis and calcinosis, ongoing inflammatory activity contributes to the calcium deposition in the media of small arteries, as well as perivascular and periarticular tissues. We report three patients whose soft-tissue calcification syndromes dramatically resolved after undergoing HSCT. METHODS: Three patients referred for refractory SLE underwent HSCT at a tertiary care medical center. SLE serologies and clinical features before and after HSCT were recorded. RESULTS: Despite receiving >6 months of intravenous cyclophosphamide (CYC), three SLE patients showed signs of persistent lupus activity, including severe soft-tissue calcification. The first patient was on haemodialysis and developed severe calciphylaxis with large ulcers and tissue necrosis. The second patient had calcinosis, with palpable crystals extruding from ulcers. The third patient had calcinosis characterized by subcutaneous nodules and plaques. Because prior conventional therapies had failed, the three were treated with high-dose CYC, anti-thymocyte globulin and HSCT. They have been followed post-HSCT for 26-38 months, with excellent clinical responses, including sustained resolution of skin abnormalities. CONCLUSIONS: The successful treatment of advanced calcium deposition by aggressive immune ablation underscores the contribution of SLE-mediated inflammation to soft-tissue calcification syndromes.
Subject(s)
Calcinosis/etiology , Calcinosis/therapy , Connective Tissue Diseases/etiology , Connective Tissue Diseases/therapy , Hematopoietic Stem Cell Transplantation , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/therapy , Adolescent , Adult , Arm , Calcinosis/pathology , Calciphylaxis/etiology , Calciphylaxis/pathology , Calciphylaxis/therapy , Connective Tissue Diseases/pathology , Female , Humans , Leg , Lupus Erythematosus, Systemic/pathology , Skin Ulcer/etiology , Skin Ulcer/pathology , Skin Ulcer/therapyABSTRACT
Phototherapy is nowadays one of the main methods used in dermatology. It can be used alone or in combination with oral and/or topical treatment. The action of ultraviolet radiation is exploited for the treatment of many diseases. This paper presents the application of various phototherapy methods, their side-effects and ways of preventing them.
Subject(s)
Connective Tissue Diseases/therapy , Phototherapy/methods , Skin Diseases/therapy , Balneology/methods , Humans , PUVA Therapy , Phototherapy/adverse effects , Ultraviolet TherapyABSTRACT
Significant progress has been made in interventional pain management. Despite this progress, patients continue to present a diagnostic and therapeutic challenge. Steroidal and nonsteroidal anti-inflammatory medications have limited use in degenerative painful conditions of connective tissue. Regenerative injection therapy, also known as prolotherapy, is a viable, type-specific treatment for such pathology. Several placebo-controlled studies, together with uncontrolled studies, indicate the effectiveness of regenerative injection therapy in treating painful ligament and tendon pathology. As stated in July 2003 by Mooney, this treatment has advanced "from the fringe to the frontier of medical care."